Why the damage accumulates

Sattar attributes the pattern to a cluster of related conditions that often travel together in people with type 2 diabetes.

"Our findings clearly show how the serious complications associated with type 2 diabetes rise sharply over time as the often common combination in patients of obesity, abnormal blood fats, high blood pressure and higher blood sugar damages blood vessels and vital organs," Sattar said in a statement.

In plain terms, diabetes rarely acts alone. Excess weight, unhealthy cholesterol and triglyceride levels, elevated blood pressure, and high blood glucose reinforce one another, wearing down the small blood vessels that supply the kidneys and the heart muscle itself. Over years, that sustained damage translates into the complication rates the study measured.

The case for early action

The findings underline a straightforward clinical message. Because complications begin accumulating quickly — nearly a third of patients hit a serious endpoint within five years — the window for prevention opens at diagnosis, if not earlier.

"Our results emphasize the critical importance of detecting and treating type 2 diabetes thoroughly at the earliest opportunity to help reduce the risk of serious complications," Sattar said.

Early detection of diabetes itself may carry the greatest payoff. Many people live with elevated blood sugar for years before receiving a diagnosis, and the study's clock starts only at that moment. Some of the observed damage may have been accumulating before researchers began counting.

Important caveats

The results come with limitations worth keeping in mind. The researchers presented the study at a conference rather than in a peer-reviewed publication, so other scientists have not yet scrutinized the full methods and data. The figures describe average risk across a very large and diverse population, and individual risk varies widely depending on factors such as age, weight, blood pressure control, and how early the diabetes was caught.

The size of the study population — nearly 1.62 million adults — is its main strength, giving the risk estimates unusual statistical stability. Even so, the analysis describes associations over time; it cannot prove that early, aggressive treatment will reduce the risks it documents, although that is the strong implication Sattar draws.

What patients and doctors can take from it

For clinicians, the numbers argue for treating kidney health as a front-line concern from the day of diagnosis, not an afterthought. Regular urine and blood tests to detect declining kidney function, alongside cardiovascular risk management, could help catch trouble before it compounds — the study's own figures show how one complication raises the odds of the next.

For patients, the message is less alarming than it may first appear. These are risks, not certainties, and roughly two-thirds of people in the study had not developed kidney disease, heart failure, or died at the five-year mark. The findings sharpen, rather than darken, the picture: early diagnosis, thorough treatment, and control of blood sugar, blood pressure, and blood fats remain the levers most likely to keep both the kidneys and the heart working well.